STOCK TITAN

Salarius Pharmaceuticals, Inc. (SLRX) Free Cash Flow by Year

SLRX

Salarius Pharmaceuticals, Inc. recorded an outflow of $5.4M in free cash flow in fiscal year 2025. This represents a decrease of 19.4% from the prior fiscal year. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters Salarius Pharmaceuticals, Inc. has filed alongside them.

FY2025 annual
Free Cash Flow -$5.4M
YoY -19.4%
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

SLRX Free Cash Flow by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY22FY21FY20FY19FY18FY17FY16FY15
Free Cash Flow-$5.4M-19.4%-$4.5MN/AN/A-$10.2M+1.1%-$10.3M+10.9%-$11.6M-377.2%$4.2M+115.0%-$27.8M+14.6%-$32.6M-55.2%-$21.0M

SLRX Free Cash Flow by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'23Q3'23Q2'23
Free Cash FlowN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A

What free cash flow means

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.

More Salarius Pharmaceuticals, Inc. financials

Frequently Asked Questions

What was Salarius Pharmaceuticals, Inc.'s free cash flow in fiscal year 2025?

Salarius Pharmaceuticals, Inc. recorded an outflow of $5.4M in free cash flow in fiscal year 2025.

How fast is Salarius Pharmaceuticals, Inc.'s free cash flow growing?

Salarius Pharmaceuticals, Inc. (SLRX) free cash flow fell by 19.4% year over year, from -$4.5M to -$5.4M in fiscal year 2025.

How has Salarius Pharmaceuticals, Inc.'s free cash flow changed over the years?

Across the 11 fiscal years this page covers, Salarius Pharmaceuticals, Inc. (SLRX) free cash flow went from -$21.0M in fiscal year 2015 to -$5.4M in fiscal year 2025.

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Salarius Pharmaceuticals, Inc. (SLRX) reported on that line in every period on record.